The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.95
Bid: 4.80
Ask: 5.10
Change: -0.03 (-0.60%)
Spread: 0.30 (6.25%)
Open: 4.855
High: 4.98
Low: 4.80
Prev. Close: 4.98
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collaboration with synthetic data specialist

20 Jun 2023 07:30

RNS Number : 2820D
Seeing Machines Limited
20 June 2023
 

PRESS RELEASE

Seeing Machines joins forces with Devant, synthetic data specialist, for enhanced transport safety

Collaboration accelerates Machine Learning capabilities as regulatory deadlines approach

CANBERRA + STOCKHOLM, 20 June 2023 - To support the training and development of its Machine Learning capabilities, Seeing Machines Limited (LSE:SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, today announces a collaboration with Swedish startup, Devant, a world leading supplier of human centric synthetic data.

Seeing Machines is revolutionising global transport safety, developing and licensing proprietary eye-tracking technology, underpinned by bespoke AI that monitors driver attentiveness, to some of the world's leading automotive manufacturers. Its class-leading driver and occupant monitoring system (DMS/OMS) technology is powered by Machine Learning networks, which need to be trained and validated using large sets of high-quality data.

This collaboration brings together Seeing Machines' 20+ years' experience and unrivalled access to human behavioural insights with Devant's specialist rendering capabilities, leaving Seeing Machines uniquely positioned to accelerate the development and training of its Machine Learning networks that underpin its advanced DMS and OMS solutions.

Seeing Machines' move to incorporate the world's most advanced synthetic data into its DMS development flow is part of a larger Digital Engineering initiative critical to achieving market leading development efficiency, to meet the growing demand for more in-cabin, driver and occupant monitoring capabilities as new transport safety regulation deadlines approach. The successful incorporation of computer-generated synthetic data follows Seeing Machines' research and development of a realism taxonomy considering all system attribute and noise factors (i.e. human appearance and behavioural variations, optical, electronic, and vehicle cabin environment), impacting the real-world fidelity of data ultimately used to augment the development, training and eventually validation, if its in-cabin AI vision software.

Seeing Machines' scientific approach to validate what makes a computer-generated human "real enough" in practice, prosecuted on a feature-by-feature basis for DMS/OMS, combined with Devant's unrivalled capability and focus to solving the unique but critical in-cabin human synthesis challenges, is unlocking an abundant source of synthetic data suitable for accelerated development of in-cabin sensing technology. It is also satisfying Seeing Machines' demanding requirements needed to achieve best-in-class safety outcomes and to uphold its reputation for delivery of real-world reliability and performance.

Commenting on the partnership, Paul McGlone, CEO at Seeing Machines said: "With a wave of new transport safety regulations coming into force around the world, it is increasingly vital for the advanced Machine Learning networks that underpin our AI-driven technology to access reliable data of the highest quality, accuracy and realism.

"Our mission to get everyone home safely has never been more relevant. That is why we have partnered with Devant, a leader in its field, to help deliver on our promise of providing our customers with bespoke, mission-critical solutions that enhance driver safety.

"Devant is uniquely able to capture and translate the subtlest movements and human behaviours, producing a granularity of detail that has, until now, been impossible to simulate. This unique approach to data creation will allow our Machine Learning to cover a broader range of human activity, improving on delivery times without compromising quality."

Richard Bremer, CEO and Co-Founder at Devant, added: "We pride ourselves on delivering best in class synthetic data, combining unparalleled 3D human animation, computer graphics and engineering to deliver millions of images and animations. We are pleased to be partnering with an innovative market leader like Seeing Machines, which is delivering a step change in transport safety by harnessing its class leading DMS technology."

Seeing Machines uses advanced machine vision technology to monitor driver behaviours under a full spectrum of demanding lighting conditions, including through sunglasses. This data is processed to interpret driver attention state, focus, drowsiness and impairment levels to provide critical inputs in real-time to advanced driver assistance systems (ADAS), as well as to vehicle cockpit, comfort and convenience systems.

With DMS set to become mandatory around the world this decade, Seeing Machines continues to grow as a world-leader in driver and occupant monitoring systems, with close to 900,000 cars on the road today featuring its safety technology underpinned by 15 expanding automotive programs for 10 individual global OEMs.

Download Seeing Machines' white paper, "Do not believe your eyes. The use of synthetic data for driver monitoring product development".

Devant will be exhibiting at InCabin, the world's thought-leading event for interior intelligence specialists, taking place between 20 and 22 June 2023 in Brussels. Devant will be showcasing the Devant NCAP Validation Service developed in close collaboration with Seeing Machines, targeting Tier 1s, OEMs and regulators to accelerate in-cabin monitoring system validation by providing high-quality human-centric synthetic data.

 

For further information, please contact:

Seeing Machines

Sophie Nicoll

 

sophie.nicoll@seeingmachines.com

+61 419 149 683

Devant

Richard Bremer

 

richard@devant.ai

+46 76 222 5787

 

About Seeing Machines

Seeing Machines (LSE: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical. www.seeingmachines.com

About Devant

Devant provides human-centric synthetic data to support the training, testing and validation of Machine Learning networks. Offering unparalleled data customization, Devant delivers lifelike 3D simulations that enable Machine Learning developers to generate any real-life scenario. This empowers businesses to boost the performance of their computer vision applications and reducing Machine Learning bias. Delivering a unique combination of speed and accuracy, Devant enables customers to specify their own adjustable parameters, returning high-quality data in a matter of days. www.devant.ai

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASESSMSEDSEEM
Date   Source Headline
17th Mar 20107:05 amRNSSignificant DSS deal with BHP Billiton
15th Mar 20108:22 amRNSMajor DSS Contract Win
12th Feb 20107:00 amRNSSEEING MACHINES SIGNS MAJOR DEAL
5th Feb 20104:09 pmRNSQuarterly Newsletter
26th Nov 20099:15 amRNSResult of AGM
6th Nov 20097:00 amRNSChange of Chairman
26th Oct 20098:25 amRNSTrueField Analyzer
23rd Sep 20097:00 amRNSAnnual Financial Report
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.